What is the cost-effectiveness of person-centred care? Passed
Wednesday May 15, 2024 11:15 - 12:15 G3
Panelists: Benjamin Harvey, Hanna Gyllensten, Jana Bergholtz, Johan Jarl, Laura Pirhonen Nørmark, Salma Pardhan
Track: Health economics
Issue: In the symposium we will focus on how to evaluate the cost-effectiveness of person-centred care (PCC). An ongoing systematic review explored the current evidence, and research groups from GPCC have conducted a sizeable proportion of all such studies. Although most studies have shown PCC to be cost-effective, we also identify several limitations in the current knowledge, potentially limiting its usefulness for decision-making. An example is the lack of process evaluations exploring studies where PCC interventions were found to be dominated by care as usual, and the lack of clarity on how the intervention differed from its comparator. Aim: That the audience become familiar with the current state of the evidence for cost-effectiveness of PCC and can assess the role for future such economic evaluations in decision-making. The discussion will explore opportunities and pitfalls in conducting such studies. Outline: Short introduction to priorities in healthcare and the role of health economics in decision-making. A 5-minute presentations from each participant will be followed by a moderator-led discussion about how to develop future high quality economic evaluations of PCC. This will explore the most pressing issues for decision-makers, where the audience will have the opportunity to pose questions. Participants: Moderator and patient-representative: JB. SP: set the GPCC literature in perspective to the international literature. LP: presenting the evidence from the early GPCC-projects single study economic evaluations. HG: presenting the evidence from studies exploring implementation cost for PCC. BH: presenting an overview of (core) outcomes for economic evaluation of PCC. JJ: provide perspective on economic evaluations of healthcare programmes and health economics. Materials: Audience should bring phones or laptops to be able to post questions to the moderator.
Seminar type
Pre-recorded + On-site
Lecture type
Panel
Conference
GCPCC
Authors
Hanna Gyllensten, Benjamin P Harvey, Salma Pardhan, Laura Pirhonen Nørmark, Johan Jarl , Jana Bergholtz
Lecturers
Benjamin Harvey Panelist
University of Gothenburg
Hanna Gyllensten Panelist
Associate professor
University of Gothenburg
About
Hanna is a registered pharmacist with a background in community pharmacy and as a ward pharmacist. She is PhD (Medicine) since 2014 and her thesis was exploring the economic impact of drug-related morbidity, including e.g., adverse drug reactions and sub-therapeutic effects of drug therapy. Hanna is now a senior lecturer at University of Gothenburg, and Associated professor in health care sciences.
She is leading one of the three focus areas within GPCC; directed towards development, adaptation and evaluation of person-centred care. In that role she is responsible for on one of the centers strategic initiatives towards governance for person-centred care, and leads the research group examining health economic aspects of person-centred care.
Research
Hannas research focuses on health economic aspects of, in particular, chronic diseases. Examples are economic evaluations of person-centred interventions in healthcare, based on data collected within clinical trials and complemented by data from national and regional registers. Her other research projects include mainly (register-based) observational research. The studies uses national registers, sometimes complemented by data from population survey or collected from medical records, to study e.g., societal costs resulting from disease.
Jana Bergholtz Panelist
Johan Jarl Panelist
Associate professor
Lund University
Health economist with primary research interest in economic evaluations and register-based studies on consequences of disease.
Laura Pirhonen Nørmark Panelist
University of Copenhagen
Salma Pardhan Panelist
Doktorand
University of Gothenburg; GPCC
My name is Salma Pardhan, and I am pursuing a PhD in the area of health economics, studying patients with congenital heart disease. I received a Masters in Economics from Queen's University (Ontario, Canada), and a Masters in Public Health with Health Economics from Gothenburg University (Gothenburg, Sweden). I also have over ten years experience working as a policy analyst and advisor for a number of departments across the health portfolio within the federal Government of Canada.